Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Five antithrombin variants, four associated with thrombosis

H L Fitton1, I D Walker, L Jones

  • 1University of Cambridge Department of Haematology, UK.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Seroprevalence of total antibodies to hepatitis A virus in haemophiliacs in the West of Scotland.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Quality control of point of care INR devices is essential.

BMJ (Clinical research ed.)·2016
Same author

Confirmation of genetic testing results in haemostasis and thrombosis - survey of current practice in the field.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Stability of coagulation proteins in lyophilized plasma.

International journal of laboratory hematology·2014
Same author

T-cell antigen receptors: fact and artefact.

Immunology today·2014

Researchers identified five antithrombin mutations via polymerase chain reaction sequencing. Four mutations link to thrombosis, causing antithrombin deficiency, while one variant has no functional impact.

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • Antithrombin is a crucial protein regulating blood coagulation.
  • Genetic mutations can lead to antithrombin deficiency, increasing thrombotic risk.
  • Understanding these mutations aids in diagnosing and managing thrombotic disorders.

Purpose of the Study:

  • To identify and characterize novel mutations in the antithrombin gene.
  • To correlate identified mutations with antithrombin deficiency and thrombotic events.
  • To investigate the functional and structural consequences of these genetic variations.

Main Methods:

  • Direct sequencing of amplified antithrombin gene exons using polymerase chain reaction (PCR).
  • Analysis of mutation types (nonsense, missense, deletion) and their locations.

Related Experiment Videos

  • Predictive assessment of structural and functional impacts based on mutation type and residue conservation.

    • Main Results:

    • Five distinct mutations in the antithrombin gene were identified.
    • Four mutations were associated with thrombosis; three caused Type I deficiency, and one exhibited Type II deficiency characteristics.
    • One mutation (Val 415-->Asp) was found incidentally with no apparent link to thrombosis in the affected family member.

    Conclusions:

    • Novel antithrombin mutations contribute to thrombotic risk and deficiency states.
    • Specific mutations have predictable structural and functional consequences impacting antithrombin activity.
    • Genetic analysis of antithrombin is vital for understanding hereditary thrombophilia.